Regulation of α2-adrenoceptors in human vascular smooth muscle cells
Open Access
- 1 January 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 286 (1) , H59-H67
- https://doi.org/10.1152/ajpheart.00268.2003
Abstract
This study analyzed the regulation of α2-adrenoceptors (α2-ARs) in human vascular smooth muscle cells (VSMs). Saphenous veins and dermal arterioles or VSMs cultured from them expressed high levels of α2-ARs (α2C> α2A, via RNase protection assay) and responded to α2-AR stimulation [5-bromo- N-(4,5-dihydro-1 H-imidazol-2-yl)-6-quinoxalinamine (UK-14,304, 1 μM)] with constriction or calcium mobilization. In contrast, VSMs cultured from aorta did not express α2-ARs and neither cultured cells nor intact aorta responded to UK-14,304. Although α2-ARs (α2C>> α2A) were detected in aortas, α2C-ARs were localized by immunohistochemistry to VSMs of adventitial arterioles and not aortic media. In contrast with aortas, aortic arterioles constricted in response to α2-AR stimulation. Reporter constructs demonstrated higher activities for α2A- and α2C-AR gene promoters in arteriolar compared with aortic VSMs. In arteriolar VSMs, serum increased expression of α2C-AR mRNA and protein but decreased expression of α2A-ARs. Serum induction of α2C-ARs was reduced by inhibition of p38 mitogen-activated protein kinase (MAPK) with 2 μM SB-202190 or dominant-negative p38 MAPK. UK-14,304 (1 μM) caused calcium mobilization in control and serum-stimulated cells: in control VSMs, the response was inhibited by the α2A-AR antagonist BRL-44408 (100 nM) but not by the α2C-AR antagonist MK-912 (1 nM), whereas after serum stimulation, MK-912 (1 nM) but not BRL-44408 (100 nM) inhibited the response. These results demonstrate site-specific expression of α2-ARs in human VSMs that reflects differential activity of α2-AR gene promoters; namely, high expression and function in venous and arteriolar VSMs but no detectable expression or function in aortic VSMs. We found that α2C-ARs can be dramatically and selectively induced via a p38 MAPK-dependent pathway. Therefore, altered expression of α2C-ARs may contribute to pathological changes in vascular function.Keywords
This publication has 20 references indexed in Scilit:
- Subtype-specific neuronal differentiation of PC12 cells transfected with α2-adrenergic receptorsEuropean Journal of Cell Biology, 2002
- Methylation of the estrogen receptor-α gene promoter is selectively increased in proliferating human aortic smooth muscle cellsCardiovascular Research, 2000
- Gene targeting — homing in on α2-adrenoceptor-subtype functionTrends in Pharmacological Sciences, 1997
- Role of the Amino Terminus of the Third Intracellular Loop in Agonist-Promoted Downregulation of the α2A-Adrenergic ReceptorBiochemistry, 1997
- RAYNAUD'S PHENOMENONRheumatic Disease Clinics of North America, 1996
- G Protein-coupled Receptor Kinase Specificity for Phosphorylation and Desensitization of α2-Adrenergic Receptor SubtypesPublished by Elsevier ,1996
- Localization of Messenger RNA for Three Distinct α2-Adrenergic Receptor Subtypes in Human TissuesAnesthesiology, 1994
- Comparative study of postsynaptic α-adrenoceptors in aorta obtained from human and other mammalian speciesPharmacological Research, 1991
- The effects of cooling on human saphenous vein reactivity to adrenergic agonistsJournal of Vascular Surgery, 1990
- α1-Adrenoceptor subclassification in vascular smooth muscleTrends in Pharmacological Sciences, 1986